Brain mapping-based model of Δ 9-tetrahydrocannabinol effects on connectivity in the pain matrix

Neuropsychopharmacology

Volumn 41, Issue 6, 2016, Pages 1659-1669

  Walter, Carmen ^a   Oertel, Bruno G ^a   Felden, Lisa ^a   Kell, Christian A ^a   Nöth, Ulrike ^a   Vermehren, Johannes ^a   Kaiser, Jochen ^a   Deichmann, Ralf ^a   Lötsch, Jörn ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TETRAHYDROCANNABINOL; VANILLIN; ANALGESIC AGENT; DRONABINOL;

ADULT; AMYGDALOID NUCLEUS; ANALGESIC ACTIVITY; ANTERIOR INSULA; ARTICLE; BRAIN MAPPING; CEREBELLUM; CLINICAL ARTICLE; CONNECTOME; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG MECHANISM; EUPHORIA; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NAUSEA; NEUROIMAGING; PAIN; PAIN INTENSITY; POSTCENTRAL GYRUS; PRIMARY SOMATOSENSORY CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY SOMATOSENSORY CORTEX; SIDE EFFECT; SOMATOSENSORY CORTEX; THALAMUS; TREMOR; VOMITING; BIOLOGICAL MODEL; BRAIN; DIAGNOSTIC IMAGING; DRUG EFFECTS; FUNCTIONAL NEUROIMAGING; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; ANALGESICS; BRAIN; BRAIN MAPPING; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRONABINOL; FEMALE; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, NEUROLOGICAL; NEURAL PATHWAYS; PAIN; SOMATOSENSORY CORTEX; THALAMUS; YOUNG ADULT;

EID: 84963563051     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.336     Document Type: Article

References (94)

1. Ab Aziz CB, Ahmad AH. (2006). The role of the thalamus in modulating pain. Malays J Med Sci 13: 11-18
2. Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. (2007). Cannabis in painful HIV-Associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68: 515-521
3. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, et al. (2007). Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10: 870-879
4. Andersson JL, Hutton C, Ashburner J, Turner R, Friston K. (2001). Modeling geometric deformations in EPI time series. Neuroimage 13: 903-919
5. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. (2005). Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9: 463-484
6. Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, et al. (2003). Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 6: 750-757
7. Berman JS, Symonds C, Birch R. (2004). Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 112: 299-306
8. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P, et al. (2012). Induction of psychosis by Delta9-Tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 69: 27-36
9. Bingel U, Quante M, Knab R, Bromm B, Weiller C, Büchel C. (2002). Subcortical structures involved in pain processing: evidence from single-Trial fMRI. Pain 99: 313-321
10. Bishay P, Schmidt H, Marian C, Haussler A, Wijnvoord N, Ziebell S, et al. (2010). R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One 5: e10628
11. Bloom AS, Dewey WL. (1978). A comparison of some pharmacological actions of morphine and delta9-Tetrahydrocannabinol in the mouse. Psychopharmacology (Berl) 57: 243-248
12. Breivogel CS, Childers SR. (1998). The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5(6 Pt B): 417-431
13. Bushnell MC, Duncan GH, Hofbauer RK, Ha B, Chen JI, Carrier B. (1999). Pain perception: is there a role for primary somatosensory cortex?. Proc Natl Acad Sci USA 96: 7705-7709
14. Chesher GB, Dahl CJ, Everingham M, Jackson DM, Marchant-Williams H, Starmer GA. (1973). The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice. Br J Pharmacol 49: 588-594
15. Chevaleyre V, Takahashi KA, Castillo PE. (2006). Endocannabinoidmediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76
16. Cooper ZD, Comer SD, Haney M. (2013). Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology 38: 1984-1992
17. D'Souza DC, Fridberg DJ, Skosnik PD, Williams A, Roach B, Singh N, et al. (2012). Dose-related modulation of event-related potentials to novel and target stimuli by intravenous delta(9)-THC in humans. Neuropsychopharmacology 37: 1632-1646
18. Dervaux A, Bourdel MC, Laqueille X, Krebs MO. (2013). Neurological soft signs in non-psychotic patients with cannabis dependence. Addict Biol 18: 214-221
19. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613
20. Dodel S, Poline JB, Anton JL, Brett M (eds) (2004). The influence of heart beat and respiration on functional connectivity networks. Biomedical Imaging: Nano to Macro, 2004. IEEE International Symposium; 15-18 April 2004
21. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, et al. (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25: 1325-1335
22. Farrell M, Ritson B. (2001). Cannabis and health. Br J Psychiatry 178: 98
23. Fernandez E, Turk DC. (1992). Sensory and affective components of pain: separation and synthesis. Psychol Bull 112: 205-217
24. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. (1997). Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 6: 218-229
25. Friston KJ, Fletcher P, Josephs O, Holmes A, Rugg MD, Turner R. (1998). Event-related fMRI: characterizing differential responses. Neuroimage 7: 30-40
26. Friston KJ, Harrison L, PennyW(2003). Dynamic causal modelling. Neuroimage 19: 1273-1302
27. Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, et al. (1995). Analysis of fMRI time-series revisited. Neuroimage 2: 45-53
28. Gasquoine PG. (2014). Contributions of the insula to cognition and emotion. Neuropsychol Rev 24: 77-87
29. Gitelman DR, Penny WD, Ashburner J, Friston KJ. (2003). Modeling regional and psychophysiologic interactions in fMRI: the importance of hemodynamic deconvolution. Neuroimage 19: 200-207
30. Greenwald MK, Stitzer ML. (2000). Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59: 261-275
31. Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang J, et al. (2002). Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47: 1202-1210
32. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al. (2004). Segregation of two endocannabinoid-hydrolyzing enzymes into pre-And postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20: 441-458
33. Hall W, Solowij N. (1998). Adverse effects of cannabis. Lancet 352: 1611-1616
34. Hari R, Portin K, Kettenmann B, Jousmaki V, Kobal G. (1997). Right-hemisphere preponderance of responses to painful CO2 stimulation of the human nasal mucosa. Pain 72: 145-151
35. Heifets BD, Castillo PE. (2009). Endocannabinoid signaling and long-Term synaptic plasticity. Annu Rev Physiol 71: 283-306
36. Hochberg Y. (1988). A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75: 800-802
37. Hollister LE, Gillespie HK, Ohlsson A, Lindgren JE, Wahlen A, Agurell S. (1981). Do plasma concentrations of delta 9-Tetrahydrocannabinol reflect the degree of intoxication?. J Clin Pharmacol 21(8-9 Suppl): 171S-177S
38. Hummel T, Gruber M, Pauli E, Kobal G. (1994). Chemosomatosensory event-related potentials in response to repetitive painful chemical stimulation of the nasal mucosa. Electroencephalogr Clin Neurophysiol 92: 426-432
39. Hutton C, Bork A, Josephs O, Deichmann R, Ashburner J, Turner R. (2002). Image distortion correction in fMRI: a quantitative evaluation. Neuroimage 16: 217-240
40. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380
41. Kehl LJ, Hamamoto DT, Wacnik PW, Croft DL, Norsted BD, Wilcox GL, et al. (2003). A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain 103: 175-186
42. Kobal G. (1981). Elektrophysiologische Untersuchungen des Menschlichen Geruchsinnes. Thieme-Verlag: Stuttgart
43. Kobal G. (1985). Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 22: 151-163
44. Kobal G, Hummel C, Nuernberg B, Brune K. (1990). Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions 29: 342-359
45. Kofalvi A, Pereira MF, Rebola N, Rodrigues RJ, Oliveira CR, Cunha RA. (2007). Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus. Br J Pharmacol 151: 551-563
46. Kraft B. (2012). Is there any clinically relevant cannabinoid-induced analgesia?. Pharmacology 89: 237-246
47. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. (2000). Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120-131
48. Lee MC, Ploner M, Wiech K, Bingel U, Wanigasekera V, Brooks J, et al. (2013). Amygdala activity contributes to the dissociative effect of cannabis on pain perception. Pain 154: 124-134
49. Leknes S, Tracey I. (2007). Hippocampus and Entorhinal Complex, Functional Imaging. Chapter of the Encyclopedia of Pain. Springer Verlag: Berlin, Heidelberg
50. Liang M, Mouraux A, Iannetti GD. (2011). Parallel processing of nociceptive and non-nociceptive somatosensory information in the human primary and secondary somatosensory cortices: evidence from dynamic causal modeling of functional magnetic resonance imaging data. J Neurosci 31: 8976-8985
51. Lindsey KP, Glaser ST, Gatley SJ. (2005). Imaging of the brain cannabinoid system. Handb Exp Pharmacol 168: 425-443
52. Lötsch J, Ahne G, Kunder J, Kobal G, Hummel T. (1998). Factors affecting pain intensity in a pain model based upon tonic intranasal stimulation in humans. Inflamm Res 47: 446-450
53. Lötsch J, Stuck B, Hummel T. (2006). The human mu-opioid receptor gene polymorphism 118A4G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci 120: 1218-1224
54. Lötsch J, Walter C, Felden L, Noth U, Deichmann R, Oertel BG. (2012). The human operculo-insular cortex is pain-preferentially but not pain-exclusively activated by trigeminal and olfactory stimuli. PLoS One 7: e34798
55. Lovinger DM. (2008). Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 184: 435-477
56. Lozano-Ondoua AN, Wright C, Vardanyan A, King T, Largent-Milnes TM, Nelson M, et al. (2010). A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. Life Sci 86: 646-653
57. Maihofner C, Herzner B, Otto Handwerker H. (2006). Secondary somatosensory cortex is important for the sensory-discriminative dimension of pain: a functional MRI study. Eur J Neurosci 23: 1377-1383
58. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239
59. Manzanares J, Julian M, Carrascosa A. (2006). Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol 4: 239-257
60. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534
61. Martin BR, Lichtman AH. (1998). Cannabinoid transmission and pain perception. Neurobiol Dis 5(6 Pt B): 447-461
62. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564
63. Mechoulam R, Gaoni Y. (1965). Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 21: 1223-1229
64. Menon V, Uddin LQ. (2010). Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214: 655-667
65. Mugler JP 3rd, Brookeman JR. (1991). Rapid three-dimensional T1-weighted MR imaging with the MP-RAGE sequence. J Magn Reson Imaging 1: 561-567
66. Noyes R Jr, Brunk SF, Baram DA, Canter A. (1975). Analgesic effect of delta-9-Tetrahydrocannabinol. J Clin Pharmacol 15: 139-143
67. Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D. (2007). Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebocontrolled clinical trial. Pain 133: 210-220
68. Oertel BG, Preibisch C, Martin T, Walter C, Gamer M, Deichmann R, et al. (2012). Separating brain processing of pain from that of stimulus intensity. Hum Brain Mapp 33: 883-894
69. Oertel BG, Preibisch C, Wallenhorst T, Hummel T, Geisslinger G, Lanfermann H, et al. (2008). Differential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther 83: 577-588
70. Ogawa S, Lee TM, Kay AR, Tank DW. (1990). Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87: 9868-9872
71. Oshiro Y, Quevedo AS, McHaffie JG, Kraft RA, Coghill RC. (2009). Brain mechanisms supporting discrimination of sensory features of pain: a new model. J Neurosci 29: 14924-14931
72. Piomelli D. (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884
73. Ploghaus A, Tracey I, Clare S, Gati JS, Rawlins JN, Matthews PM. (2000). Learning about pain: the neural substrate of the prediction error for aversive events. Proc Natl Acad Sci USA 97: 9281-9286
74. Price DD. (2000). Psychological and neural mechanisms of the affective dimension of pain. Science 288: 1769-1772
75. Price DD. (2002). Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv 2: 392-403, 339
76. Reeh PW, Kress M. (2001). Molecular physiology of proton transduction in nociceptors. Curr Opin Pharmacol 1: 45-51
77. Roberts JD, Gennings C, Shih M. (2006). Synergistic affective analgesic interaction between delta-9-Tetrahydrocannabinol and morphine. Eur J Pharmacol 530: 54-58
78. Schneider F, Habel U, Holthusen H, Kessler C, Posse S, Muller-Gartner HW, et al. (2001). Subjective ratings of pain correlate with subcortical-limbic blood flow: an fMRI study. Neuropsychobiology 43: 175-185
79. Sim K, Cullen T, Ongur D, Heckers S. (2006). Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm 113: 907-928
80. Solowij N, Michie PT, Fox AM. (1991). Effects of long-Term cannabis use on selective attention: an event-related potential study. Pharmacol BiochemBehav 40: 683-688
81. Stephan KE, Penny WD, Daunizeau J, Moran RJ, Friston KJ. (2009). Bayesian model selection for group studies. Neuroimage 46: 1004-1017
82. Stephan KE, Penny WD, Moran RJ, den Ouden HE, Daunizeau J, Friston KJ. (2010). Ten simple rules for dynamic causal modeling. Neuroimage 49: 3099-3109
83. Svendsen KB, Jensen TS, Bach FW. (2004). Does the cannabinoid dronabinol reduce central pain in multiple sclerosis?. Randomised double blind placebo controlled crossover trial. BMJ 329: 253
84. Tart CT. (1970). Marijuana intoxication common experiences. Nature 226: 701-704
85. Tarun AS, Bryant B, Zhai W, Solomon C, Shusterman D. (2003). Gene expression for carbonic anhydrase isoenzymes in human nasal mucosa. Chem Senses 28: 621-629
86. Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, Menon RS, et al. (2002). Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 22: 2748-2752
87. van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, Zelaya F, et al. (2011). Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. Int J Neuropsychopharmacol 14: 1377-1388
88. Walker JM, Huang SM. (2002). Cannabinoid analgesia. Pharmacol Ther 95: 127-135
89. Walker JM, Strangman NM, Huang SM. (2001). Cannabinoids and pain. Pain Res Manag 6: 74-79
90. Walter C, Dimova V, Bu J, Parnham MJ, Oertel BG, Lotsch J. (2015). Inverted perceptual judgment of nociceptive stimuli at threshold level following inconsistent cues. PLoS One 10: e0132069
91. Walter C, Ferreiros N, Bishay P, Geisslinger G, Tegeder I, Lotsch J. (2013). Exogenous Delta9-Tetrahydrocannabinol influences circulating endogenous cannabinoids in humans. J Clin Psychopharmacol 33: 699-705
92. Walter C, Oertel BG, Lötsch J. (2015). THC may reproducibly induce electrical hyperalgesia in healthy volunteers. Eur J Pain 19: 516-518
93. Wang YY, Chang RB, Liman ER. (2010). TRPA1 is a component of the nociceptive response to CO2. J Neurosci 30: 12958-12963
94. Worsley KJ, Friston KJ. (1995). Analysis of fMRI time-series revisited-Again. Neuroimage 2: 173-181